The Sarvagun Story: In India’s crowded wellness market, Ayurveda has never lacked believers. What it has often lacked, however, is structure, consistency and measurable outcomes. Rahul Agarwal believes that gap is exactly where the next big healthcare opportunity lies and Sarvagun is his answer.
Backed by RASA Group, Sarvagun is emerging as a modern Ayurveda and holistic healthcare brand that aims to make traditional healing accountable to contemporary expectations. And early traction, according to company data, suggests the bet is beginning to pay off.
The brand says it has served over 2,000 patients across its centres so far and is recording around 35% month-on-month growth, putting it on track to target an annual recurring revenue (ARR) of ₹10-12 crore over the next 12 months.
But for Agarwal, Sarvagun is less about rapid scaling and more about fixing what he sees as Ayurveda’s long-standing credibility challenge.
Sarvagun: Making Ayurveda Relevant Again
Today, the urban consumer in India is looking beyond immediate fixes. Lifestyle diseases, stress-related ailments, and chronic problems have forced consumers to search for preventive and wholesome solutions. Yet, Ayurveda faces difficulty in competing with modern medical systems.
Sarvagun’s approach, according to the company, is to professionalise Ayurveda through measurable outcomes, structured care pathways and data-informed personalisation, bridging traditional healing with modern healthcare delivery.
Rahul Agarwal describes the idea simply: Ayurveda must move beyond vague promises. “Sarvagun was created to make Ayurveda more relevant and accountable for today’s consumers. By focusing on outcomes, personalization, and root-cause treatment, the brand is building a scalable healthcare model that goes beyond symptomatic relief,” Agarwal says.
The emphasis here is clear: less mysticism, more measurable recovery.
Inside the Sarvagun Experience
Sarvagun positions itself as combining classical Ayurvedic science with standardized modern protocols, focusing on structured and outcome-driven healing rather than ad-hoc therapies.
Its treatment ecosystem includes:
- Personalised treatment plans
- Panchakarma detox therapies
- Nutrition guidance
- Yoga and meditation-based wellness support
All of this is directed toward managing lifestyle and chronic conditions through long-term care, rather than short-term symptom suppression.
In practice, this means patients aren’t just prescribed herbal formulations or therapies but are guided through lifestyle corrections, diet adjustments and ongoing wellness routines.
The company also highlights telemedicine-led support alongside physical centres, indicating a hybrid model aimed at improving continuity of care.
The Man Behind the Push
Rahul Agarwal is not new to consumer wellness. He previously founded Organic Harvest, a brand that rode the early wave of India’s organic beauty and personal care movement. That experience, insiders say, helped him understand how consumer trust in natural products evolves, and where credibility gaps remain.
With RASA Group, Agarwal has now built a diversified platform operating across multiple sectors, from food and real estate to services and adventure experiences, with Sarvagun representing its healthcare and wellness vertical.
The group currently operates six strategic verticals, aiming to build scalable, category-led ventures across India.
Expansion on the Horizon
Sarvagun’s next chapter is expansion. RASA Group says it plans to scale Sarvagun pan-India over the next three to five years, with the ambition of building a nationally recognised healthcare platform.
There is also a longer-term financial roadmap. The group says it is evaluating a potential listing of RASA Group or one of its sub-brands within the next two to three years, as it expands its footprint.
For Sarvagun, this means growth will likely move beyond metros into emerging urban healthcare markets where preventive care demand is rising.
Sarvagun’s story is not just about one brand scaling. It reflects a larger shift in Indian healthcare consumption, where consumers are increasingly blending modern medicine with holistic wellness.
If Ayurveda can be made structured, outcome-led and consistent, Agarwal believes, it can move from being a secondary option to a mainstream healthcare choice.
The next few years will show whether Sarvagun can deliver on that promise at scale. But if early numbers and expansion plans hold, Rahul Agarwal may be attempting something larger than building another wellness brand.
He may be trying to rebuild trust in an ancient system, one measurable outcome at a time.
Also Read: Supertails Raises $30 Million to Expand Pet Care & Vet Services in India
